FENGYUAN PHARMACEUTICAL(000153.SZ)

Last Updated 00:00:00
longbridge loading

Top Midday Stories: NextEra, Dominion to Combine in All-Stock Deal; Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case

Fidelity·
US
NEE
-1.99%
US
D
-0.59%
Fidelity·
US
NEE
-1.99%
US
D
-0.59%

Luminex Multiplex Assays Market Projected to Reach USD 3.89 Billion by 2033, Driven by Rising Demand for High-Throughput Biomarker Profiling and Standardized Multiplex Testing Workflows: Verified Market Research

fidelity·
fidelity·

Monday Wrap: Bank wealth inflows, STI risks, and AI job gaps

Singapore Business Review·
SG
D05
-1.13%
SG
O39
-0.81%
SG
U11
-0.42%
Singapore Business Review·
SG
D05
-1.13%
SG
O39
-0.81%
SG
U11
-0.42%

FENGYUAN PHARMACEUTICAL released its performance for the first three quarters, with a net profit attributable to the parent company of 100 million yuan, a year-on-year decrease of 31.92%

Zhitong·
SZ
000153
-1.62%
Zhitong·
SZ
000153
-1.62%

Zhitong A-share lock-up release overview | October 13

Zhitong·
SZ
000758
-0.57%
SZ
001872
+0.09%
SZ
000153
-1.62%
Zhitong·
SZ
000758
-0.57%
SZ
001872
+0.09%
SZ
000153
-1.62%

FENGYUAN PHARMACEUTICAL: The transfer of part of the company's shares by the controlling shareholder and its concerted parties has been completed

Zhitong·
SZ
000153
-1.62%
Zhitong·
SZ
000153
-1.62%

FENGYUAN PHARMACEUTICAL's controlling shareholder plans to transfer 5.1% of its shares, which will not affect control

Zhitong·
SZ
000153
-1.62%
Zhitong·
SZ
000153
-1.62%

Pharmaceutical and medical stocks continue to strengthen, with FENGYUAN PHARMACEUTICAL hitting the limit up, Hengrui Pharma rising over 7%, and Haisco, BIOCAUSE HEILEN PHARMA, Yatai pharm, and Yirui Biologics also following suit

Wallstreetcn·
SZ
002653
+0.91%
SZ
301211
-1.90%
SZ
002370
-4.33%
Wallstreetcn·
SZ
002653
+0.91%
SZ
301211
-1.90%
SZ
002370
-4.33%

FENGYUAN PHARMACEUTICAL released its 2024 annual performance, with a net profit attributable to the parent company of 161 million yuan, a year-on-year increase of 0.97%

Zhitong·
SZ
000153
-1.62%
Zhitong·
SZ
000153
-1.62%

The value of domestic sales under the duty-free policy for processing and value-added in Hainan Free Trade Port has exceeded 7 billion yuan

USHK News·
SZ
001215
+2.54%
SZ
000153
-1.62%
SZ
002082
-4.98%
USHK News·
SZ
001215
+2.54%
SZ
000153
-1.62%
SZ
002082
-4.98%
© 2026 Longbridge｜Disclaimer